Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

Kenneth E. Sherman, Susan D. Rouster, Raymond T. Chung, +1

Clinical Infectious Diseases

Hepatitis C VirusAntiviral DrugHuman Immunodeficiency VirusViral HepatitisHuman Retrovirus +15

Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY

A. J. van der Lely, Beverly M. K. Biller, Thierry Brue, +9

The Journal of Clinical Endocrinology & Metabolism

A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS

Christina M. Marra, Natasa Rajicic, David E. Barker, +10

AIDS

Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension

Luke J. Laffin, David Rodman, James M. Luther, +5

JAMA

Occult Hepatitis B in HIV-Infected Patients

Norah J. Shire, Susan D. Rouster, Natasa Rajicic, +1

JAIDS Journal of Acquired Immune Deficiency Syndromes

Hepatitis DHepatologyOccult HbvViral HepatitisImmunology +12

Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study

Keith Chirgwin, Richard Hafner, Catherine Leport, +10

Clinical Infectious Diseases

AsthmaImmunodeficienciesImmunologyPharmacotherapyHuman Immunodeficiency Virus +17

Two-Year Safety and Virologic Efficacy of Maraviroc in Treatment-Experienced Patients With CCR5-Tropic HIV-1 Infection: 96-Week Combined Analysis of MOTIVATE 1 and 2

William D. Hardy, Roy M. Gulick, Howard Mayer, +5

JAIDS Journal of Acquired Immune Deficiency Syndromes

Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4+ Cell Rises in HIV-Infected Patients

Nicholas Funderburg, Magdalena Kalinowska, James D. Eason, +6

PLoS ONE

A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients’ modifiable risk factor profile

Joshua S. Benner, Leif Erhardt, Martina Flammer, +10

International Journal of Clinical Practice

Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy

Ezio Ghigo, Beverly M. K. Biller, Annamaria Colao, +5

Journal of Endocrinological Investigation

Long-acting OctreotideRadiation OncologyMedical TherapyAcromegaly Naïve